Sanuwave Health (SNWV) Profit Swing To US$11.8m TTM Challenges Earnings Quality Concerns

Simply Wall St.03-28

SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622078668?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-03-28 11:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622078668","market":"hk","top_or_hot":-1,"title":"Sanuwave Health (SNWV) Profit Swing To US$11.8m TTM Challenges Earnings Quality Concerns","media":"Simply Wall St.","content":"<div>\n<p>SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/sanuwave-health-snwv-profit-swing-to-us118m-ttm-challenges-e\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanuwave Health (SNWV) Profit Swing To US$11.8m TTM Challenges Earnings Quality Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanuwave Health (SNWV) Profit Swing To US$11.8m TTM Challenges Earnings Quality Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-28 11:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/sanuwave-health-snwv-profit-swing-to-us118m-ttm-challenges-e><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/sanuwave-health-snwv-profit-swing-to-us118m-ttm-challenges-e\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TTM","symbol_name":"塔塔汽车","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/sanuwave-health-snwv-profit-swing-to-us118m-ttm-challenges-e","article_id":"2622078668","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/sanuwave-health-snwv-profit-swing-to-us118m-ttm-challenges-e","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622078668","pubTimestamp":1774667565,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the company moved to positive earnings over the period. Over recent quarters, revenue has ranged from US$9.3 million in Q1 2025 to US$13.1 million in Q4 2025, with basic EPS swinging from a loss of US$0.66 per share to a gain of US$1.20 in Q3 2025 and US$0.71 in Q4 2025. This sets up a cleaner...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TTM":"塔塔汽车","SNWV":"SANUWAVE Health, Inc."},"translate_title":"Sanuwave Health(SNWV)利润波动至1180万美元TTM挑战盈利质量担忧","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TTM":1.5,"SNWV":1.5},"content_text":"SANUWAVE Health (SNWV) closed out FY 2025 with Q4 revenue of US$13.1 million and basic EPS of US$0.71, while trailing 12 month figures show revenue of US$44.1 million and basic EPS of US$1.38 as the company moved to positive earnings over the period. Over recent quarters, revenue has ranged from US$9.3 million in Q1 2025 to US$13.1 million in Q4 2025, with basic EPS swinging from a loss of US$0.66 per share to a gain of US$1.20 in Q3 2025 and US$0.71 in Q4 2025. This sets up a cleaner profitability picture that puts margins and their sustainability firmly in focus for investors. See our full analysis for SANUWAVE Health. With the headline numbers on the table, the next step is to line these results up against the most common narratives around SANUWAVE Health to see which storylines the latest margins support and which ones they start to challenge. See what the community is saying about SANUWAVE Health NasdaqGM:SNWV Revenue & Expenses Breakdown as at Mar 2026 AdvertisementFrom Losses to US$11.8m TTM Profit  On a trailing 12 month basis, SANUWAVE Health moved from a net loss of US$31.4 million in Q4 2024 to net income of US$11.8 million in Q4 2025, with TTM revenue over the same window at US$44.1 million. Analysts' consensus view links this swing into profit with forecasts for earnings growth of about 20.9% per year and revenue growth of about 24% per year. However, Q1 2025 still showed a quarterly net loss of US$5.7 million on US$9.3 million of revenue, which underlines that the turnaround story is not a straight line.  Valuation Caught Between P/E and DCF  The shares trade on a P/E of 13.5x, below the US market average of 18.4x and the US Medical Equipment industry average of 27.7x. The DCF fair value in this dataset is US$16.38 per share compared with a current share price of US$18.61 and an analyst price target of US$43.50. Consensus narrative supporters point to forecast revenue growth of roughly 24% per year and earnings growth of about 20.9% per year as context for the P/E being below the broad market. At the same time, the DCF fair value sitting below the share price and the reliance on non cash earnings both suggest you cannot take the analyst price target at face value without checking how comfortable you are with the cash flow and risk assumptions behind it.  Non Cash Earnings and Interest Coverage Risks  Risk flags highlight that interest payments are not well covered by earnings and that reported earnings contain a high level of non cash items, even as FY 2025 quarterly net income shifted from a loss of US$5.7 million in Q1 to profits of US$1.1 million, US$10.3 million, and US$6.1 million in Q2, Q3, and Q4 respectively. Critics highlight that the move into profit and the analyst target of US$43.50 rely heavily on reported net income, yet the weak interest coverage and non cash heavy earnings profile mean the recent US$11.8 million of TTM net income may not translate cleanly into cash that can comfortably service debt.  This directly challenges a bullish reading of the rapid shift from a TTM loss of US$31.4 million in Q4 2024 to a TTM profit of US$11.8 million, because the quality of those earnings is as important as their size. It also gives weight to the DCF fair value of US$16.38 being below the US$18.61 share price, since a cash flow based approach is more sensitive to any gap between accounting profit and actual cash generation.   On top of these headline risks and rewards, it is worth seeing how the full set of growth drivers and balance sheet pressures fit together over time, not just this year’s swing back to profit, so you can judge how robust the story really is before you commit more capital. 🐻 SANUWAVE Health Bear Case Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for SANUWAVE Health on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. Plenty in this update points in different directions, so treat it as a starting point rather than the finish line. Review the figures yourself before forming a view using these 3 key rewards and 2 important warning signs. See What Else Is Out There Heavy reliance on non cash earnings, weak interest coverage, and a share price sitting above DCF fair value all raise questions about balance sheet strength and resilience. If you want ideas where financial footing may look steadier, check out the solid balance sheet and fundamentals stocks screener (39 results) to quickly surface companies with stronger fundamentals and potentially lower funding risk.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622078668","isCrawlerRequest":true}